Omalizumab Improves Efficacy of Oral Immunotherapy for Multiple Food Allergies
Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show. After 36 weeks, more than 80 per cent of children who received omalizumab and OIT could safely consume two-gram portions of at least two [...]